The following is a summary of “Bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals ...
Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...
Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.
A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus ...
Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving ...
2d
Hosted on MSNFDA Approves Groundbreaking Rapid-Acting Insulin Biosimilar Merilog, Offering New Hope for Millions Battling DiabetesThe U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin ...
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
Study results indicated that controlling diabetes with insulin helps to prevent the emergence of antibiotic-resistant S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results